prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations [2]

New England Journal of Medicine

Volumn 357, Issue 15, 2007, Pages 1555-1556

  Roukos, Dimitrios H ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; BREAST TUMOR; FEMALE; GENETIC SCREENING; GENETICS; MORTALITY; MUTATION; NOTE; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC SCREENING; HUMANS; MUTATION; PROGNOSIS;

EID: 35348911366     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc072301     Document Type: Letter

References (1)

1. Roukos DH, Briasoulis E. Individualized preventive and therapeutic management of hereditary breast ovarian cancer. Nat Clin Pract Oncol 2007;4:578-90.